43 results
Page 2 of 3
S-3ASR
kzwxct
4 Aug 22
Automatic shelf registration
5:29pm
8-K
EX-99.1
09wj8f
4 Aug 22
Lyell Immunopharma Reports Second Quarter Financial Results and Business Highlights
4:16pm
8-K
EX-99.1
d55d09m5a qa2u6
10 May 22
Lyell Immunopharma Reports First Quarter Financial Results and Business Highlights
4:14pm
DEF 14A
habu3em jhscs
28 Apr 22
Definitive proxy
4:11pm
10-K
EX-10.16
8bms2yf 78834sgnoq
29 Mar 22
Annual report
4:20pm
10-K
sqbh 4cfr1ng917x8c
29 Mar 22
Annual report
4:20pm
8-K
EX-99.1
p3lch4c
29 Mar 22
Lyell Immunopharma Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
4:15pm
8-K
EX-99.1
fm25v
12 Nov 21
Lyell Immunopharma Reports Third Quarter 2021 Financial Results and Business Highlights
8:20am
10-Q
9ier15a aw
12 Aug 21
Quarterly report
5:07pm
8-K
EX-99.1
bd8h6e1qpwd0 c39bgn
12 Aug 21
Lyell Immunopharma Reports Second Quarter 2021 Financial Results and Business Highlights
4:18pm
424B4
d2y403g0gl4qu
18 Jun 21
Prospectus supplement with pricing info
12:00am
S-1/A
7um6 4e0v3jddxp5ruvh
9 Jun 21
IPO registration (amended)
7:12am
S-1/A
EX-10.15
9tv cohqpk9jfukcu
9 Jun 21
IPO registration (amended)
7:12am
S-1
EX-10.15
qcuvwj0tb
25 May 21
IPO registration
5:28pm
S-1
2bjv r40pe3j3y8j
25 May 21
IPO registration
5:28pm
S-1
EX-10.18
tylozp
25 May 21
IPO registration
5:28pm
DRS/A
ljr cz03si84
12 May 21
Draft registration statement (amended)
12:00am